L. Reuteri ATCC PTA 5289 + L. Reuteri DSM 17938 in Pregnant Women

NAUnknownINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

December 30, 2019

Conditions
Periodontitis and Pregnancy
Interventions
DIETARY_SUPPLEMENT

Probiotic

L. reuteri DSM 17938 \& L. reuteri ATCC PTA 5289 ) will be given at a dose of 2x10\^8 Colony Forming Units (CFU). One lozenges is to be taken twice per day (one in the morning and one in the afternoon) giving a total daily dose of at least 4x108 CFU/day.

OTHER

Placebo

Placebo will have identical appearance, taste, and flavor, except for lacking the bacteria. One lozenges will be taken twice per day (one in the morning and one in the afternoon)

Trial Locations (2)

14080

RECRUITING

Hospital General Dr. Manuel Gea Gonzalez, Mexico City

70121

NOT_YET_RECRUITING

Department of Pediatric. Università di Bari; Ospedale Pediatrico Giovanni XXIII, Bari

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Bari

OTHER

collaborator

BioGaia AB

INDUSTRY

lead

Innovacion y Desarrollo de Estrategias en Salud

OTHER

NCT03375125 - L. Reuteri ATCC PTA 5289 + L. Reuteri DSM 17938 in Pregnant Women | Biotech Hunter | Biotech Hunter